- Home
- OSUR vs TPVG Comparison
OSUR vs TPVG Comparison
Compare OSUR & TPVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- TPVG
- Stock Information
- Founded
- OSUR 2000
- TPVG 2013
- Country
- OSUR United States
- TPVG United States
- Employees
- OSUR N/A
- TPVG N/A
- Industry
- OSUR Medical/Dental Instruments
- TPVG Other Consumer Services
- Sector
- OSUR Health Care
- TPVG Consumer Discretionary
- Exchange
- OSUR Nasdaq
- TPVG Nasdaq
- Market Cap
- OSUR 223.0M
- TPVG 253.9M
- IPO Year
- OSUR 1986
- TPVG N/A
- Fundamental
- Price
- OSUR $3.06
- TPVG $7.03
- Analyst Decision
- OSUR Hold
- TPVG Hold
- Analyst Count
- OSUR 1
- TPVG 6
- Target Price
- OSUR $3.00
- TPVG $6.55
- AVG Volume (30 Days)
- OSUR 783.1K
- TPVG 248.1K
- Earning Date
- OSUR 08-05-2025
- TPVG 08-06-2025
- Dividend Yield
- OSUR N/A
- TPVG 17.14%
- EPS Growth
- OSUR N/A
- TPVG N/A
- EPS
- OSUR N/A
- TPVG 0.93
- Revenue
- OSUR $161,626,000.00
- TPVG $101,260,000.00
- Revenue This Year
- OSUR N/A
- TPVG N/A
- Revenue Next Year
- OSUR $6.20
- TPVG $6.30
- P/E Ratio
- OSUR N/A
- TPVG $7.57
- Revenue Growth
- OSUR N/A
- TPVG N/A
- 52 Week Low
- OSUR $2.36
- TPVG $5.53
- 52 Week High
- OSUR $4.92
- TPVG $9.17
- Technical
- Relative Strength Index (RSI)
- OSUR 57.98
- TPVG 55.73
- Support Level
- OSUR $2.92
- TPVG $6.93
- Resistance Level
- OSUR $3.08
- TPVG $7.16
- Average True Range (ATR)
- OSUR 0.14
- TPVG 0.17
- MACD
- OSUR 0.01
- TPVG -0.01
- Stochastic Oscillator
- OSUR 84.85
- TPVG 56.33
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About TPVG TriplePoint Venture Growth BDC Corp.
TriplePoint Venture Growth BDC Corp is a closed-end, non-diversified management investment company. Its investment objective is to maximize its total return to stockholders in the form of current income and, to a lesser extent, capital appreciation. The fund focuses on companies operating in the fields of biofuels, business applications software, wireless communications equipment, e-commerce, clothing and accessories, conferencing equipment and services, personal goods, financial institutions and services, entertainment, mixed retailing, and healthcare services. Geographically, all the operations of the firm function through the region of the United states.